HEADER TRANSCRIPTION 10-JUN-11 3ZQT TITLE TARGETING THE BINDING FUNCTION 3 SITE OF THE ANDROGEN RECEPTOR THROUGH TITLE 2 IN SILICO MOLECULAR MODELING COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANDROGEN RECEPTOR; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, RESIDUES 664-919; COMPND 5 SYNONYM: DIHYDROTESTOSTERONE RECEPTOR, NUCLEAR RECEPTOR SUBFAMILY 3 COMPND 6 GROUP C MEMBER 4; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ESCHERICHIA COLI; SOURCE 3 ORGANISM_TAXID: 469008; SOURCE 4 STRAIN: BL21(DE3); SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_VECTOR: PGEX KEYWDS TRANSCRIPTION, SMALL MOLECULE INHIBITOR EXPDTA X-RAY DIFFRACTION AUTHOR N.A.LACK,P.AXERIO,P.TAVASSOLI,K.KUCHENBECKER,F.Q.HAN,K.H.CHAN,C.FEAU, AUTHOR 2 E.LEBLANC,E.TOMLINSON,R.K.GUY,P.S.RENNIE,A.CHERKASOV REVDAT 3 20-DEC-23 3ZQT 1 REMARK REVDAT 2 11-JAN-12 3ZQT 1 JRNL REVDAT 1 07-DEC-11 3ZQT 0 JRNL AUTH N.A.LACK,P.AXERIO-CILIES,P.TAVASSOLI,F.Q.HAN,K.H.CHAN, JRNL AUTH 2 C.FEAU,E.LEBLANC,E.T.GUNS,R.K.GUY,P.S.RENNIE,A.CHERKASOV JRNL TITL TARGETING THE BINDING FUNCTION 3 (BF3) SITE OF THE HUMAN JRNL TITL 2 ANDROGEN RECEPTOR THROUGH VIRTUAL SCREENING. JRNL REF J.MED.CHEM. V. 54 8563 2011 JRNL REFN ISSN 0022-2623 JRNL PMID 22047606 JRNL DOI 10.1021/JM201098N REMARK 2 REMARK 2 RESOLUTION. 2.29 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.29 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 93.6 REMARK 3 NUMBER OF REFLECTIONS : 11306 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.232 REMARK 3 R VALUE (WORKING SET) : 0.229 REMARK 3 FREE R VALUE : 0.307 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 571 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.29 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.35 REMARK 3 REFLECTION IN BIN (WORKING SET) : 573 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 64.82 REMARK 3 BIN R VALUE (WORKING SET) : 0.2420 REMARK 3 BIN FREE R VALUE SET COUNT : 24 REMARK 3 BIN FREE R VALUE : 0.4930 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2032 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 48 REMARK 3 SOLVENT ATOMS : 26 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 49.10 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.75 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.58000 REMARK 3 B22 (A**2) : -2.82000 REMARK 3 B33 (A**2) : -0.76000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.492 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.319 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.247 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.960 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.922 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2202 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2997 ; 1.569 ; 1.978 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 264 ; 5.361 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 99 ;34.700 ;23.535 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 388 ;17.792 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 14 ;16.469 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 327 ; 0.112 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1663 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1300 ; 0.807 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2118 ; 1.509 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 902 ; 2.207 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 879 ; 3.360 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 3ZQT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 10-JUN-11. REMARK 100 THE DEPOSITION ID IS D_1290048673. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : ASYMMETRIC CUT SINGLE CRYSTAL REMARK 200 SI(220) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11306 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.340 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.6 REMARK 200 DATA REDUNDANCY : 6.400 REMARK 200 R MERGE (I) : 0.09000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.34 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 73.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.40 REMARK 200 R MERGE FOR SHELL (I) : 0.66000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2AM9 REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 7.5 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 27.95600 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 36.46050 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.08550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 36.46050 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 27.95600 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.08550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ILE A 664 REMARK 465 GLU A 665 REMARK 465 GLY A 666 REMARK 465 TYR A 667 REMARK 465 GLU A 668 REMARK 465 CYS A 669 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 836 CG CD CE NZ REMARK 470 LYS A 847 CG CD CE NZ REMARK 470 ASN A 848 CG OD1 ND2 REMARK 470 GLU A 893 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASN A 727 O25 30Z A 1920 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 844 -7.23 -52.57 REMARK 500 LYS A 845 80.53 -161.62 REMARK 500 LYS A 847 -93.23 -62.73 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE TES A 1000 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 1001 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 30Z A 1920 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2AMB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANDROGEN RECEPTOR LIGAND BINDINGDOMAIN REMARK 900 IN COMPLEX WITH TETRAHYDROGESTRINONE REMARK 900 RELATED ID: 2AO6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGANDBINDING REMARK 900 DOMAIN BOUND WITH TIF2(III) 740-753 PEPTIDE ANDR1881 REMARK 900 RELATED ID: 1XOW RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGANDBINDING REMARK 900 DOMAIN BOUND WITH AN ANDROGEN RECEPTOR NH2 -TERMINAL PEPTIDE, AR20- REMARK 900 30, AND R1881 REMARK 900 RELATED ID: 2AX8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDINGDOMAIN REMARK 900 W741L MUTANT IN COMPLEX WITH S-1 REMARK 900 RELATED ID: 2AX7 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDINGDOMAIN REMARK 900 T877A MUTANT IN COMPLEX WITH S-1 REMARK 900 RELATED ID: 1T5Z RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDINGDOMAIN REMARK 900 (LBD) WITH DHT AND A PEPTIDE DERIVED FROM ITSPHYSIOLOGICAL REMARK 900 COACTIVATOR ARA70 REMARK 900 RELATED ID: 1Z95 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND- BINDINGDOMAIN REMARK 900 W741L MUTANT COMPLEX WITH R-BICALUTAMIDE REMARK 900 RELATED ID: 1XJ7 RELATED DB: PDB REMARK 900 COMPLEX ANDROGEN RECEPTOR LBD AND RAC3 PEPTIDE REMARK 900 RELATED ID: 2AM9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANDROGEN RECEPTOR LIGAND BINDINGDOMAIN REMARK 900 IN COMPLEX WITH TESTOSTERONE REMARK 900 RELATED ID: 2YHD RELATED DB: PDB REMARK 900 HUMAN ANDROGEN RECEPTOR IN COMPLEX WITH AF2 SMALL MOLECULE INHIBITOR REMARK 900 RELATED ID: 1XQ3 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN ANDROGEN RECEPTOR LIGANDBINDING REMARK 900 DOMAIN BOUND WITH R1881 REMARK 900 RELATED ID: 2YLO RELATED DB: PDB REMARK 900 TARGETING THE BINDING FUNCTION 3 SITE OF THE ANDROGEN RECEPTOR REMARK 900 THROUGH IN SILICO MOLECULAR MODELING REMARK 900 RELATED ID: 1T65 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDINGDOMAIN REMARK 900 WITH DHT AND A PEPTIDE DERIVED FORM ITSPHYSIOLOGICAL COACTIVATOR REMARK 900 GRIP1 NR BOX 2 BOUND IN A NON-HELICAL CONFORMATION REMARK 900 RELATED ID: 1E3G RELATED DB: PDB REMARK 900 HUMAN ANDROGEN RECEPTOR LIGAND BINDING IN COMPLEX WITH THE LIGAND REMARK 900 METRIBOLONE (R1881) REMARK 900 RELATED ID: 2YLP RELATED DB: PDB REMARK 900 TARGETING THE BINDING FUNCTION 3 SITE OF THE ANDROGEN RECEPTOR REMARK 900 THROUGH IN SILICO MOLECULAR MODELING REMARK 900 RELATED ID: 1GS4 RELATED DB: PDB REMARK 900 STRUCTURAL BASIS FOR THE GLUCOCORTICOID RESPONSE IN A MUTANT HUMAN REMARK 900 ANDROGEN RECEPTOR (ARCCR) DERIVED FROM AN ANDROGEN-INDEPENDENT REMARK 900 PROSTATE CANCER REMARK 900 RELATED ID: 2AMA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN ANDROGEN RECEPTOR LIGAND BINDINGDOMAIN REMARK 900 IN COMPLEX WITH DIHYDROTESTOSTERONE REMARK 900 RELATED ID: 2YLQ RELATED DB: PDB REMARK 900 TARGETING THE BINDING FUNCTION 3 SITE OF THE ANDROGEN RECEPTOR REMARK 900 THROUGH IN SILICO MOLECULAR MODELING REMARK 900 RELATED ID: 2AX9 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDINGDOMAIN IN REMARK 900 COMPLEX WITH R-3 REMARK 900 RELATED ID: 2AX6 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDINGDOMAIN REMARK 900 T877A MUTANT IN COMPLEX WITH HYDROXYFLUTAMIDE REMARK 900 RELATED ID: 2AXA RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDINGDOMAIN IN REMARK 900 COMPLEX WITH S-1 REMARK 900 RELATED ID: 1T63 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE ANDROGEN RECEPTOR LIGAND BINDINGDOMAIN REMARK 900 WITH DHT AND A PEPTIDE DERIVED FROM ITSPHYSIOLOGICAL COACTIVATOR REMARK 900 GRIP1 NR BOX3 DBREF 3ZQT A 664 919 UNP P10275 ANDR_HUMAN 664 919 SEQRES 1 A 256 ILE GLU GLY TYR GLU CYS GLN PRO ILE PHE LEU ASN VAL SEQRES 2 A 256 LEU GLU ALA ILE GLU PRO GLY VAL VAL CYS ALA GLY HIS SEQRES 3 A 256 ASP ASN ASN GLN PRO ASP SER PHE ALA ALA LEU LEU SER SEQRES 4 A 256 SER LEU ASN GLU LEU GLY GLU ARG GLN LEU VAL HIS VAL SEQRES 5 A 256 VAL LYS TRP ALA LYS ALA LEU PRO GLY PHE ARG ASN LEU SEQRES 6 A 256 HIS VAL ASP ASP GLN MET ALA VAL ILE GLN TYR SER TRP SEQRES 7 A 256 MET GLY LEU MET VAL PHE ALA MET GLY TRP ARG SER PHE SEQRES 8 A 256 THR ASN VAL ASN SER ARG MET LEU TYR PHE ALA PRO ASP SEQRES 9 A 256 LEU VAL PHE ASN GLU TYR ARG MET HIS LYS SER ARG MET SEQRES 10 A 256 TYR SER GLN CYS VAL ARG MET ARG HIS LEU SER GLN GLU SEQRES 11 A 256 PHE GLY TRP LEU GLN ILE THR PRO GLN GLU PHE LEU CYS SEQRES 12 A 256 MET LYS ALA LEU LEU LEU PHE SER ILE ILE PRO VAL ASP SEQRES 13 A 256 GLY LEU LYS ASN GLN LYS PHE PHE ASP GLU LEU ARG MET SEQRES 14 A 256 ASN TYR ILE LYS GLU LEU ASP ARG ILE ILE ALA CYS LYS SEQRES 15 A 256 ARG LYS ASN PRO THR SER CYS SER ARG ARG PHE TYR GLN SEQRES 16 A 256 LEU THR LYS LEU LEU ASP SER VAL GLN PRO ILE ALA ARG SEQRES 17 A 256 GLU LEU HIS GLN PHE THR PHE ASP LEU LEU ILE LYS SER SEQRES 18 A 256 HIS MET VAL SER VAL ASP PHE PRO GLU MET MET ALA GLU SEQRES 19 A 256 ILE ILE SER VAL GLN VAL PRO LYS ILE LEU SER GLY LYS SEQRES 20 A 256 VAL LYS PRO ILE TYR PHE HIS THR GLN HET TES A1000 21 HET SO4 A1001 5 HET 30Z A1920 22 HETNAM TES TESTOSTERONE HETNAM SO4 SULFATE ION HETNAM 30Z 4-[(2R,3S)-3-[(3,4-DIHYDROXYPHENYL)METHYL]-2- HETNAM 2 30Z METHYLBUTYL]BENZENE-1,2-DIOL FORMUL 2 TES C19 H28 O2 FORMUL 3 SO4 O4 S 2- FORMUL 4 30Z C18 H22 O4 FORMUL 5 HOH *26(H2 O) HELIX 1 1 PRO A 671 GLU A 681 1 11 HELIX 2 2 SER A 696 ALA A 721 1 26 HELIX 3 3 GLY A 724 LEU A 728 5 5 HELIX 4 4 HIS A 729 ASN A 758 1 30 HELIX 5 5 ASN A 771 SER A 778 1 8 HELIX 6 6 MET A 780 GLN A 798 1 19 HELIX 7 7 THR A 800 PHE A 813 1 14 HELIX 8 8 ASN A 823 CYS A 844 1 22 HELIX 9 9 ASN A 848 LYS A 883 1 36 HELIX 10 10 PRO A 892 GLN A 902 1 11 HELIX 11 11 GLN A 902 SER A 908 1 7 SHEET 1 AA 2 LEU A 762 ALA A 765 0 SHEET 2 AA 2 LEU A 768 PHE A 770 -1 O LEU A 768 N ALA A 765 SHEET 1 AB 2 ILE A 815 PRO A 817 0 SHEET 2 AB 2 VAL A 911 PRO A 913 -1 O LYS A 912 N ILE A 816 SITE 1 AC1 7 LEU A 704 ASN A 705 GLN A 711 MET A 745 SITE 2 AC1 7 MET A 749 ARG A 752 THR A 877 SITE 1 AC2 5 SER A 696 PHE A 697 LYS A 777 ARG A 779 SITE 2 AC2 5 SER A 853 SITE 1 AC3 6 PHE A 673 PRO A 723 ASN A 727 GLU A 837 SITE 2 AC3 6 ILE A 882 HOH A2008 CRYST1 55.912 66.171 72.921 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017885 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015112 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013713 0.00000